Healthcare -
Biotechnology - NASDAQ - US
$ 3.99
0.251 %
$ 258 M
Market Cap
-2.37
P/E
INZY - OPERATING INCOME
Operating Income INZY - Inozyme Pharma, Inc.
-104 M
LAST VALUE
-23.08%
2 YEAR CAGR
-37.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR